K G Nicholson
Overview
Explore the profile of K G Nicholson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
2591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nyland G, McKenzie B, Myles P, Semple M, Lim W, Openshaw P, et al.
Epidemiol Infect
. 2014 Aug;
143(6):1129-38.
PMID: 25084481
Data were extracted from the case records of UK patients admitted with laboratory-confirmed influenza A(H1N1)pdm09. White and non-White patients were characterized by age, sex, socioeconomic status, pandemic wave and indicators...
2.
Nicholson K, Abrams K, Batham S, Clark T, Hoschler K, Lim W, et al.
Health Technol Assess
. 2011 Jan;
14(55):193-334.
PMID: 21208550
Objectives: To evaluate the immunogenicity of a two-dose schedule of Baxter cell-cultured, non-adjuvanted, whole-virion H1N1 vaccine, and GlaxoSmithKline AS03(A)-adjuvanted split-virion H1N1 vaccine with respect to the EU Committee for Medicinal...
3.
Puleston R, Bugg G, Hoschler K, Konje J, Thornton J, Stephenson I, et al.
Health Technol Assess
. 2011 Jan;
14(55):1-82.
PMID: 21208547
Objective: The primary objective was to determine the proportion of babies who acquired passive immunity to A/H1N1v, born to mothers who accepted vaccination as part of the national vaccination programme...
4.
Killingley B, Greatorex J, Cauchemez S, Enstone J, Curran M, Read R, et al.
Health Technol Assess
. 2010 Oct;
14(46):237-354.
PMID: 20923613
Background: The relative importance of different routes of influenza transmission, including the role of bioaerosols, and ability of masks and/or hand hygiene to prevent transmission, remains poorly understood. Current evidence...
5.
Nguyen-Van-Tam J, Openshaw P, Hashim A, Gadd E, Lim W, Semple M, et al.
Thorax
. 2010 Jul;
65(7):645-51.
PMID: 20627925
Background: During the first wave of pandemic H1N1 influenza in 2009, most cases outside North America occurred in the UK. The clinical characteristics of UK patients hospitalised with pandemic H1N1...
6.
Stephenson I, Nicholson K
BioDrugs
. 2007 Nov;
11(4):223-8.
PMID: 18031132
Influenza is an important epidemic and pandemic illness associated with serious morbidity and mortality in unprotected communities. Patients at increased risk of infection are those with pre-existing cardiopulmonary disease including...
7.
Turner D, Wailoo A, Cooper N, Sutton A, Abrams K, Nicholson K
Vaccine
. 2005 Sep;
24(7):1035-43.
PMID: 16183177
Influenza can cause significant morbidity and mortality. Influenza vaccination is an effective and safe strategy in the prevention of influenza. Currently the National Health Service (NHS) vaccinates 'at-risk' individuals only....
8.
Stephenson I, Wood J, Nicholson K, Charlett A, Zambon M
Virus Res
. 2004 May;
103(1-2):91-5.
PMID: 15163495
Haemagglutination-inhibition (HI) tests are a simple method used to assess immune responses to influenza haemagglutinin. However, HI tests are insensitive at detection of antibody responses to avian haemagglutinin after vaccination...
9.
Stephenson I, Wood J, Nicholson K, Zambon M
J Med Virol
. 2003 May;
70(3):391-8.
PMID: 12767002
Haemagglutination-inhibition tests (HI) are used to detect increases in influenza antibody in serum. However, they are relatively insensitive for the detection of human antibody responses to avian haemagglutinin, even in...
10.
Wood J, Nicholson K, Stephenson I, Zambon M, Newman R, Major D, et al.
Med Microbiol Immunol
. 2002 Nov;
191(3-4):197-201.
PMID: 12458360
During normal interpandemic influenza seasons, immune responses to vaccines are quite predictable and meet the licensing criteria of the European Union (EU) Committee for Proprietary Medicinal Products (CPMP). In a...